Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease. 1994

W J Strittmatter, and A M Saunders, and M Goedert, and K H Weisgraber, and L M Dong, and R Jakes, and D Y Huang, and M Pericak-Vance, and D Schmechel, and A D Roses
Department of Medicine (Neurology), Joseph and Kathleen Bryan Alzheimer's Disease Research Center, Duke University Medical Center, Durham, NC 27710.

The apolipoprotein E (apoE) type 4 allele (APOE4) is a susceptibility gene for late-onset familial and sporadic Alzheimer disease. ApoE is found in some neurofibrillary tangle-bearing neurons, one of the major pathologic hallmarks of the disease. Neurofibrillary tangles contain paired helical filaments formed from hyperphosphorylated microtubule-associated protein tau. In vitro, tau binds avidly to apoE3, but not to apoE4, forming a bimolecular complex. Tau phosphorylated with a brain extract does not bind either isoform. ApoE3 binds to the microtubule-binding repeat region of tau, which is also the region that is thought to cause self-assembly into the paired helical filament. Binding studies with fragments of ApoE demonstrate that the tau-binding region of apoE3 corresponds to its receptor-binding domain and is distinct from the region that binds lipoprotein particles or beta/A4 peptide. Isoform-specific interactions of apoE with tau may regulate intraneuronal tau metabolism in Alzheimer disease and alter the rate of formation of paired helical filaments and neurofibrillary tangles.

UI MeSH Term Description Entries
D010750 Phosphoproteins Phosphoprotein
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000544 Alzheimer Disease A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57) Acute Confusional Senile Dementia,Alzheimer's Diseases,Dementia, Alzheimer Type,Dementia, Senile,Presenile Alzheimer Dementia,Senile Dementia, Alzheimer Type,Alzheimer Dementia,Alzheimer Disease, Early Onset,Alzheimer Disease, Late Onset,Alzheimer Sclerosis,Alzheimer Syndrome,Alzheimer Type Senile Dementia,Alzheimer's Disease,Alzheimer's Disease, Focal Onset,Alzheimer-Type Dementia (ATD),Dementia, Presenile,Dementia, Primary Senile Degenerative,Early Onset Alzheimer Disease,Familial Alzheimer Disease (FAD),Focal Onset Alzheimer's Disease,Late Onset Alzheimer Disease,Primary Senile Degenerative Dementia,Senile Dementia, Acute Confusional,Alzheimer Dementias,Alzheimer Disease, Familial (FAD),Alzheimer Diseases,Alzheimer Type Dementia,Alzheimer Type Dementia (ATD),Alzheimers Diseases,Dementia, Alzheimer,Dementia, Alzheimer-Type (ATD),Familial Alzheimer Diseases (FAD),Presenile Dementia,Sclerosis, Alzheimer,Senile Dementia
D001057 Apolipoproteins E A class of protein components which can be found in several lipoproteins including HIGH-DENSITY LIPOPROTEINS; VERY-LOW-DENSITY LIPOPROTEINS; and CHYLOMICRONS. Synthesized in most organs, Apo E is important in the global transport of lipids and cholesterol throughout the body. Apo E is also a ligand for LDL receptors (RECEPTORS, LDL) that mediates the binding, internalization, and catabolism of lipoprotein particles in cells. There are several allelic isoforms (such as E2, E3, and E4). Deficiency or defects in Apo E are causes of HYPERLIPOPROTEINEMIA TYPE III. Apo-E,Apo E,Apo E Isoproteins,ApoE,Apolipoprotein E Isoproteins,Apoprotein (E),Apoproteins E,Isoproteins, Apo E,Isoproteins, Apolipoprotein E
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D016875 tau Proteins Microtubule-associated proteins that are mainly expressed in neurons. Tau proteins constitute several isoforms and play an important role in the assembly of tubulin monomers into microtubules and in maintaining the cytoskeleton and axonal transport. Aggregation of specific sets of tau proteins in filamentous inclusions is the common feature of intraneuronal and glial fibrillar lesions (NEUROFIBRILLARY TANGLES; NEUROPIL THREADS) in numerous neurodegenerative disorders (ALZHEIMER DISEASE; TAUOPATHIES). tau Protein,Protein, tau,Proteins, tau
D066298 In Vitro Techniques Methods to study reactions or processes taking place in an artificial environment outside the living organism. In Vitro Test,In Vitro Testing,In Vitro Tests,In Vitro as Topic,In Vitro,In Vitro Technique,In Vitro Testings,Technique, In Vitro,Techniques, In Vitro,Test, In Vitro,Testing, In Vitro,Testings, In Vitro,Tests, In Vitro,Vitro Testing, In

Related Publications

W J Strittmatter, and A M Saunders, and M Goedert, and K H Weisgraber, and L M Dong, and R Jakes, and D Y Huang, and M Pericak-Vance, and D Schmechel, and A D Roses
January 2008, Current medicinal chemistry,
W J Strittmatter, and A M Saunders, and M Goedert, and K H Weisgraber, and L M Dong, and R Jakes, and D Y Huang, and M Pericak-Vance, and D Schmechel, and A D Roses
June 1986, Proceedings of the National Academy of Sciences of the United States of America,
W J Strittmatter, and A M Saunders, and M Goedert, and K H Weisgraber, and L M Dong, and R Jakes, and D Y Huang, and M Pericak-Vance, and D Schmechel, and A D Roses
April 2013, JAMA neurology,
W J Strittmatter, and A M Saunders, and M Goedert, and K H Weisgraber, and L M Dong, and R Jakes, and D Y Huang, and M Pericak-Vance, and D Schmechel, and A D Roses
November 2000, Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego,
W J Strittmatter, and A M Saunders, and M Goedert, and K H Weisgraber, and L M Dong, and R Jakes, and D Y Huang, and M Pericak-Vance, and D Schmechel, and A D Roses
October 2005, Chemistry and physics of lipids,
W J Strittmatter, and A M Saunders, and M Goedert, and K H Weisgraber, and L M Dong, and R Jakes, and D Y Huang, and M Pericak-Vance, and D Schmechel, and A D Roses
May 2008, Proceedings of the National Academy of Sciences of the United States of America,
W J Strittmatter, and A M Saunders, and M Goedert, and K H Weisgraber, and L M Dong, and R Jakes, and D Y Huang, and M Pericak-Vance, and D Schmechel, and A D Roses
July 1986, Proceedings of the National Academy of Sciences of the United States of America,
W J Strittmatter, and A M Saunders, and M Goedert, and K H Weisgraber, and L M Dong, and R Jakes, and D Y Huang, and M Pericak-Vance, and D Schmechel, and A D Roses
December 1996, Neuroscience letters,
W J Strittmatter, and A M Saunders, and M Goedert, and K H Weisgraber, and L M Dong, and R Jakes, and D Y Huang, and M Pericak-Vance, and D Schmechel, and A D Roses
June 1986, Proceedings of the National Academy of Sciences of the United States of America,
W J Strittmatter, and A M Saunders, and M Goedert, and K H Weisgraber, and L M Dong, and R Jakes, and D Y Huang, and M Pericak-Vance, and D Schmechel, and A D Roses
April 1995, Revue neurologique,
Copied contents to your clipboard!